The company updated the National Clinical Trial site in October. At that time the assumption estimated primary endpoint completion data moved from Sept 2016 to November 2016. They did not report whether there has been any statistical analysis change. And by that I mean that the NUMBER of event needed to reach that primary endpoint is any different. That 248-patient event number would not rise at this point. But if progression events are coming in too slowly, I would not be surprised if we eventually learn they lower the threshold number to breach.
Market Data 
Markets 
AI
